Trademark Overview
On Wednesday, January 14, 2026, a trademark application was filed for GLENMERE PHARMS with the United States Patent and Trademark Office. The USPTO has given the GLENMERE PHARMS trademark a serial number of 99593951. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 14, 2026. The GLENMERE PHARMS trademark is filed in the Advertising, Business and Retail Services category with the following description:
Wholesale, online retail, and retail store services featuring dried cannabis, CBD oil, THC oil, fresh cannabis, cannabis plants, cannabis plant seeds, cannabis edibles, beverages containing cannabis, cannabis extracts, cannabis topicals and cannabis accessories; Retail stores and distributorships featuring medical cannabis, cannabis oil and derivatives thereof; operation of a cannabis retail store dispensary; retail cannabis store; operation of a cannabis store; the aforementioned services featuring goods not containing or not for use with cannabis solely derived from hemp with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis and containing only trace amounts of naturally occurring CBD with no added CBD; providing consumer product information in the field of cannabis via a website.
